Send Inquiry

Request To Call Back

Carfilnat Carfilzomib Injection

Name: Carfilnat Carfilzomib Injection
Brand: Maheshwari Medical Agency
Price: 7800 INR
Availability: InStock

Price 7800 INR/ Piece

Get a Price/Quote

MOQ : 1 Piece

Carfilnat Carfilzomib Injection Specification

Dosage Form
Lyophilized powder for solution for injection

Life Span
2 years from the date of manufacture

Salt Composition
Carfilzomib

Origin of Medicine
India

Pacakaging (Quantity Per Box)
1 vial per box

Brand Name
Carfilnat

Packaging Type
Vial

Indication
Treatment of relapsed or refractory multiple myeloma

Drug Type
Prescription only

Ingredients
Carfilzomib

Physical Form
Injection

Function
Anti-cancer (proteasome inhibitor)

Recommended For
Multiple myeloma patients under medical supervision

Dosage
As directed by physician

Dosage Guidelines
Administer intravenously; follow healthcare providers instructions

Suitable For
Adults

Quantity
1 vial

Storage Instructions
Store below 30C, protect from light

Shelf Life After Reconstitution
Use immediately or within 24 hours if refrigerated

Product Code
CARFILNAT60MG

Therapeutic Area
Oncology

Marketed By
Natco Pharma Ltd.

Caution
To be sold by retail on the prescription of a registered oncologist only

Strength
60 mg per vial

Reconstitution Required
Yes, with sterile water for injection

Route of Administration
Intravenous

Registration Status
Prescription medicine

Carfilnat Carfilzomib Injection Trade Information

Minimum Order Quantity
1 Piece

Supply Ability
1000 Pieces Per Month

Delivery Time
7 Days

About Carfilnat Carfilzomib Injection

Spotlight on Carfilnat Carfilzomib Injection-a superlative cancer therapy radiating immediate impact for patients facing relapsed or refractory multiple myeloma. Exclusively formulated with Carfilzomib (60 mg per vial), this masterpiece from Natco Pharma Ltd. is presented as a lyophilized powder for intravenous use, requiring precise reconstitution with sterile water. Cautiously administered under oncologist supervision, Carfilnat embodies innovation in oncology care. For optimal results, use immediately post-reconstitution or within 24 hours if refrigerated. Protect from light, store below 30C. Available in a single vial, prescription only.

Dynamic Usage and Features of Carfilnat Carfilzomib Injection

Carfilnat Carfilzomib Injection is crafted for adults battling multiple myeloma, administered intravenously for targeted effectiveness. Its advanced formulation, as a lyophilized powder, ensures stability and ease of reconstitution with sterile water for injection. Exclusively for oncologist-led treatment in approved medical settings, its application media is strictly intravenous. Carfilnat's remarkable anti-cancer action delivers profound therapeutic benefits in oncology, prioritizing efficacy, safety, and distinctly engineered composition.

Export Markets, Supply Capability, and Sale Price Advantages

Carfilnat Carfilzomib Injection is actively supplied to leading export markets, including major healthcare distributors, suppliers, and traders globally, with a principal origin in India. We maintain a strong supply capability, ensuring both timely delivery and continual stock availability. Customers and partners benefit from competitive sale prices, making Carfilnat an accessible solution within the global oncology market. Each order is fulfilled swiftly, meeting international demand with precision.

FAQ's of Carfilnat Carfilzomib Injection:

Q: How should Carfilnat Carfilzomib Injection be administered?

A: Carfilnat Carfilzomib Injection must be administered intravenously by a healthcare professional, following strict medical guidelines. Dosage and frequency are specified by the prescribing oncologist based on individual patient needs.

Q: What is the recommended storage condition for Carfilnat Carfilzomib Injection?

A: This product should be stored in a dry, cool place, below 30C, and protected from light. Once reconstituted, use immediately, or refrigerate and use within 24 hours for maintained efficacy.

Q: When is Carfilnat Carfilzomib Injection indicated for use?

A: Carfilnat is indicated for adults diagnosed with relapsed or refractory multiple myeloma, under the strict supervision and prescription of a registered oncologist.

Q: What precautions must be taken during the reconstitution process?

A: Reconstitution must be performed using sterile water for injection by a qualified healthcare provider, ensuring proper handling and aseptic technique. Only use the solution immediately or refrigerate if delayed, discarding it after 24 hours if unused.

Q: Where can Carfilnat Carfilzomib Injection be purchased?

A: Carfilnat is available through authorized pharmacies and distributors upon presentation of a valid prescription from a registered oncologist. It is not sold directly to consumers and is restricted for medical use only.

Q: What are the notable benefits of Carfilnat Carfilzomib Injection?

A: Carfilnat offers targeted proteasome inhibition, providing significant therapeutic benefit for multiple myeloma patients who have relapsed or are refractory to prior treatments, under careful medical supervision.

Tell us about your requirement